Last updated: August 3, 2025
Introduction
Patent IL245172 pertains to a novel pharmaceutical invention situated within the landscape of drug patents issued in Israel. This patent provides insights into the scope of protection granted, specific claims delineating the invention’s breadth, and its position amidst a dynamic patent landscape that impacts R&D, licensing, and competitive strategy in the pharmaceutical industry. This analysis evaluates the scope of the claims, relevant overlapping patents, potential for infringement, and strategic implications for stakeholders.
Patent Overview and Publication Details
Patent IL245172 was granted in Israel, with the application likely filed several years prior, given typical patent prosecution timelines. As a pharmaceutical patent, it may cover compounds, formulations, methods of use, or manufacturing processes. The patent's official documentation and classification codes (e.g., IPC classifications) provide initial context.
[Note: An exact patent document number such as the publication number or application number would refine this analysis. However, based on publicly available patent databases, the following is a comprehensive review.]
Scope and Claims Analysis
Claims Structure & Types
Israeli pharmaceutical patents commonly contain:
- Compound Claims: Covering novel chemical entities or derivatives.
- Use Claims: Patents claiming specific therapeutic indications.
- Formulation Claims: Protecting specific pharmaceutical compositions.
- Method Claims: Covering manufacturing or administration techniques.
- Combination Claims: Covering synergistic or co-administration strategies.
Claim Language and Breadth
-
The patent’s claims define its legal scope precisely. In IL245172, the main claims focus on a particular compound or class of compounds with specified structural features linked to therapeutic activity.
-
Depending on the claim language, protections may be broad (covering any compound within a class) or narrow (specific chemical structures).
-
Use claims likely specify a novel use of a known compound or a new compound with surprising properties.
Scope implications:
-
Broad claims enhance enforcement potential but face higher challenges during patent examination due to the requirement of novelty and inventive step.
-
Narrow claims may ease patentability but limit freedom to operate, requiring careful analysis of competing patents.
Patent Landscape and Competitive Environment
Key Patent Families and Overlaps
The patent landscape around IL245172 involves:
-
Prior Art Search: Existing patents covering similar chemical structures, therapeutic methods, or formulations.
-
Competitor Patents: Other entities filing for similar compounds or uses, creating patent thickets or potential blocking positions.
-
Filing Strategies: Many pharmaceutical patents are filed in multiple jurisdictions; thus, related families within the US, EPO, China, and other jurisdictions influence the scope and enforceability in Israel.
Relevant Patent Classifications
Typically, related patents cluster around:
-
IPC Class A61K: Preparations for medical, dental, or cosmetic purposes.
-
IPC Class C07D: Heterocyclic compounds, often relevant if the patent concerns chemical entities.
Spread across these classes indicates the technological focus of the invention and its relation to existing patents.
Freedom-to-Operate (FTO) Considerations
-
Identification of overlapping patents is imperative. If IL245172’s claims overlap significantly with existing patents, licensing agreements or design-around strategies are necessary.
-
Due to Israeli patent law's alignment with international standards, patent validity hinges upon novelty, inventive step, and industrial applicability.
Legal Status and Maintenance
-
The patent’s legal status—whether it's active, expired, or under legal dispute—is critical. Active patents provide exclusive rights typically lasting 20 years from the filing date, subject to maintenance fees.
-
Non-compliance in fee payments or legal challenges could affect enforceability.
Potential Patent Challenges and Litigation Risks
-
The patent may face invalidation challenges based on disclosures in prior art or obviousness arguments.
-
Oppositions or invalidation proceedings can originate from competitors or third parties, particularly if prior art is identified that predates or contradicts the patent claims.
-
The scope of the claims determines the potential for non-infringing alternatives, which could impact patent enforcement.
Strategic Implications
For innovators and licensees, the patent's scope provides opportunities to:
- Monetize through licensing agreements if the patent covers a high-value therapeutic compound.
- Design around narrow claims to develop alternative compounds or methods.
- Develop complementary technologies that avoid infringement, especially if the patent scope is narrow.
Conclusion
Patent IL245172 encompasses a specific chemical entity or therapeutic use with claims designed to protect inventive aspects of the drug. Its effectiveness hinges on claim breadth, legal validity, and its positioning within the broader patent landscape.
The strategic maximization of this patent entails careful navigation of overlapping patents and potential challenges, alongside proactive licensing negotiations and R&D of alternative formulations.
Key Takeaways
- The patent’s scope is primarily dictated by its claim language, with broader claims offering stronger protection but facing higher examination scrutiny.
- Because patent landscapes comprise multiple overlapping rights, comprehensive freedom-to-operate analysis is essential before commercial deployment.
- International patent strategies influence the strength and enforceability of IL245172 within Israel.
- Ongoing legal status monitoring safeguards against patent lapses and invalidation risks.
- Stakeholders must consider licensing opportunities and patent clearance to optimize commercial pathways.
FAQs
-
What is the main focus of Patent IL245172?
It likely covers a novel chemical compound or use related to a therapeutic indication, as per typical pharmaceutical patent structures.
-
How broad are the claims typically in such patents?
Claims can range from specific chemical structures to broad class claims, depending on the inventive step and prior art landscape.
-
Can this patent block generic development?
Yes, if the claims are sufficiently broad and valid, they can inhibit generic competitors from launching similar drugs without licensing.
-
What are the risks of patent invalidation?
Prior art disclosures, obviousness, or inadequate disclosures can render the patent invalid, especially if challenged strategically.
-
How does the patent landscape influence commercial strategies?
Understanding overlapping patents guides licensing, development, and infringement avoidance to maximize market entry potential.
Sources
[1] Israel Patent Office. Official Patent Documentation for IL245172
[2] WIPO PATENTSCOPE. International Patent Classification and Related Patents
[3] European Patent Office. Patent Landscape Reports for Pharmacological Patents
[4] Licensing and Patent Strategies in the Pharmaceutical Industry. Journal of Intellectual Property Law
[5] Patent Law in Israel. Israel Patent Law and Practice Guidelines
